Dr. Apfel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
555 Twin Dolphin Drive, Suite 110
Redwood City, CA 94065- Is this information wrong?
Summary
- I am the Founder and CEO of SageMedic Corp., that has developed the next generation of precision oncology. This is accomplished through a functional profiling platform of fresh patient biopsies that can identify the most effective treatment independent of conventional biomarkers or genomic testing.
Education & Training
- University of Giessen Faculty of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 2009 - 2024
Clinical Trials
- Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV) Start of enrollment: 2007 Aug 01
- Monitoring Exhaled Propofol to Individualize General Anesthesia Start of enrollment: 2010 Aug 01
Publications & Presentations
PubMed
- 866 citationsA factorial trial of six interventions for the prevention of postoperative nausea and vomiting.Christian C. Apfel, Kari Korttila, Mona Abdalla, Heinz Kerger, Alparslan Turan, Ina Vedder, Carmen Zernak, Klaus Danner, Ritva Jokela, Stuart J. Pocock, Stefan Trenkle...> ;The New England Journal of Medicine. 2004 Jun 10
- 53 citationsCisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonistsN. Percie du Sert, John A. Rudd, Christian C. Apfel, P. L. R. Andrews> ;Cancer Chemotherapy and Pharmacology. 2011 Mar 1
- 18 citationsOndansetron has similar clinical efficacy against both nausea and vomiting.Ritva Jokela, Özlem Serpil Çakmakkaya, O. Danzeisen, Kari Korttila, Peter Kranke, Anuj Malhotra, A. Paura, Oliver C. Radke, D. I. Sessler, A. Soikkeli, Norbert Roewer,...> ;Anaesthesia. 2009 Feb 1
- Join now to see all
Authored Content
- The SAGE Direct Test (TM): A reliable way of functional profiling to predict the most effective treatment for cancer patientsAugust 2020
- A functional precision medicine 3D microtumor platform to identify and personalize novel indicationsMay 2020
- PDX validation of a 3D microtumor platformJune 2019
- Chemosensitivity profile of HCT-116 colorectal cancer cells in 3D spheroids compared to 2D monolayersMay 2014
- Accuracy and clinical utility of in vitro cytometric profiling to personalize chemotherapy: Preliminary findings of a systematic review and meta-analysisMay 2013
- Join now to see all
Professional Memberships
- Member
- Society of Integrative OncologyMember
External Links
- LinkedInhttps://www.linkedin.com/in/chrisapfel/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: